US Patent 9109026 Dual variable domain immunoglobulins and uses thereof
Patent 9109026 was granted and assigned to AbbVie Inc. on August, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 3, 2009
Date of Patent
August 18, 2015
Patent Application Number
12477668
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9109026 Dual variable domain immunoglobulins and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.